Fibroblast growth factor 21 (FGF21) is an endocrine regulator of lipid metabolism and energy homeostasis that has shown promise as a therapeutic against obesity and type 2 diabetes. This evidence concerns the gene FGF21 and obesity due to melanocortin 4 receptor deficiency.